Masimo (MASI) Share-based Compensation Growth (3y) (2012 - 2026)
Masimo (MASI) Share-based Compensation Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.56% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 13.40% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -14.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -14.36% |
| Sep 27, 2025 | 94.18% |
| Jun 28, 2025 | -65.67% |
| Mar 29, 2025 | 1.21% |
| Dec 28, 2024 | -11.36% |
| Mar 30, 2024 | -31.78% |
| Sep 30, 2023 | -26.65% |
| Apr 1, 2023 | 104.06% |
| Oct 1, 2022 | 46.87% |
| Jul 2, 2022 | -2.50% |
| Apr 2, 2022 | 345.83% |
| Apr 3, 2021 | 46.28% |
| Sep 26, 2020 | 90.57% |
| Mar 28, 2020 | -21.01% |
| Sep 28, 2019 | -94.43% |
| Jun 29, 2019 | 80.45% |
| Mar 30, 2019 | -65.62% |
| Mar 31, 2018 | 22.59% |
| Jul 1, 2017 | 48.14% |
| Apr 1, 2017 | 3.56% |